0:00:02i
0:00:11well to rescue
0:00:14i shall i in boston
0:00:18last year july thirty two thousand three point where diagnostic breast cancer in the united
0:00:25states
0:00:27you with cancer patients
0:00:31where i twenty five percent of so the initial hypotheses that is by caching scheme
0:00:39so that there are two
0:00:43i do not carry any individual patients that i in there is for this type
0:00:56i works closely with actually doctors in just in what are you the action
0:01:04and i is i started i know you know
0:01:14so i think you want to know what is the ones
0:01:21or pitch by the use of the coefficient will be reversed hardware realization i don't
0:01:31share a signal
0:01:36for a thirty six for all this try to a whole nation or stress balls
0:01:46i sure don't are also are probably should be so what is also
0:01:55two words
0:02:00readings i'm of the war i've abreast oncologist massachusetts general hospital
0:02:06i would like to talk about new adjutant purpose
0:02:10no actually therapy or be operated therapy refers to the administration of therapy before surgery
0:02:17from a bayesian perspective this is exciting because it could lead to downsize the chamber
0:02:22and their surgical okay
0:02:25from a research perspective mismanagement are these are exciting because presents of complete pathological response
0:02:32or no evidence of disease is associated with better outcomes
0:02:37and can serve as a surrogate more for survival
0:02:42indeed in two thousand and thirteen the f d a approved new actually purpose of
0:02:48a based on pca or as the primary endpoint
0:02:52this is the first therapy that was that will just based on these you are
0:02:58at the primary and
0:03:00in the master it we talk about new actually purpose well and we used one
0:03:05shows that to its fft who in the next section dotted his own will talk
0:03:10about future directions
0:03:13i don't use i see patients here cancer centre without regard
0:03:19you wrote a projection that is particularly relevant has been a position there is an
0:03:25apology and what we discussed in the paper is how we use this composition transducer
0:03:31with produce and further refine our care for breast cancers
0:03:37by delving into their genomic profiles and hopefully find other inhibitors that will further enhance
0:03:45both there without sacrificing analysis this is what the future areas of breast cancer research
0:03:51as well as a college general